Table 2 DWs for various outcomes
From: Estimation of disability weight for paragonimiasis: a systematic analysis
Outcome | DW mean | DW uncertainty level | Source item | Reference |
|---|---|---|---|---|
Lung outcomes | 0.279 | – | Lower respiratory infection episodes | GBD 2004 |
Pleural outcomes | 0.054 | 0.035–0.079 | Lower back pain, moderate (proxy for chest pain) | GBD 2013 |
Pericardial outcomes | 0.252 | – | Inflammatory heart disease | GBD 2004 |
Headache | 0.441 | 0.294–0.588 | Headache, migraine | GBD 2013 |
Epilepsy | 0.552 | 0.375–0.710 | Epilepsy, severe | GBD 2013 |
Motor loss | 0.061 | 0.040–0.089 | Motor impairment, moderate | GBD 2013 |
Vision impairment | 0.031 | 0.019–0.049 | Distance vision impairment, moderate | GBD 2013 |
Diarrhoea | 0.074 | 0.049–0.104 | Diarrhea, mild | GBD 2013 |
Abdominal pain | 0.060 | – | Abdominal pain | Finkelstein et al. 2007 [26] |
Hepatomegaly | 0.060 | – | Mild/moderate hepatomegaly | Finkelstein et al. 2007 [26] |
Skin rash | 0.068 | – | Oncocerciasis itching | GBD 2004 |
Subcutaneous mass | 0.023 | – | Cutaneous leishmaniasis | GBD 2004 |